Roivant Sciences Ltd. (ROIV)
NASDAQ
Closed
Oct 27, 2026
Day's Range
35.8052 wk Range
18.27Overview - ROIV - Roivant Sciences Ltd.
Key Statistics
Valuation
Enterprise Value
23.31B
P/E (Trailing)
1.94
P/E (Forward)
-21.24
PEG Ratio
-0.09
Price / Sales (TTM)
3,499.41
Price / Book
6.23
EV / EBITDA
-17.35
Profitability
Gross Margin
80.30%
Profit Margin
84.44%
Operating Margin
-25,408.11%
Return on Assets
-16.27%
Return on Equity
-8.51%
Ownership
Shares Outstanding
722.66M
Float
581.99M
Short % of Shares Outstanding
7.38%
Held by Insiders
21.38%
Held by Institutions
78.44%
Price stats
Beta
1.10
50-Day Avg
36.64
200-Day Avg
31.15
Dividends
Payout Ratio
0.00%
Analyst Consensus
13 analysts
Average price target
$ 41.95Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ROIV - Roivant Sciences Ltd.
Peers - ROIV - Roivant Sciences Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ROIVNASDAQRoivant Sciences Ltd.26.35BMarket Cap+48.45%52-week change1.95P/E (Trailing)84.44%Profit Margin
- ARGXNASDAQArgenx SE54.66BMarket Cap+4.54%52-week change30.26P/E (Trailing)31.73%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.97BMarket Cap-110.32%52-week change37.78P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.32BMarket Cap+5.36%52-week change-18.03P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.71BMarket Cap+3.36%52-week change151.22P/E (Trailing)2.14%Profit Margin
Profile Summary - ROIV - Roivant Sciences Ltd.
About
Roivant Sciences Ltd. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines and technologies through a portfolio of specialized subsidiary companies. Roivant Sciences Ltd. operates across immunology, dermatology, and other high-unmet-need therapeutic areas, with current work…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
